Merck has unveiled a new pill that slashes "bad" LDL cholesterol—by at least half in two-thirds of patients, per STAT ...

These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes ...

Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial ...

A new pill called Enlicitide may help people who don’t get results from statins. The drug showed big drops in bad cholesterol ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications may not be sufficient in helping them reach their target cholesterol levels.

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by ...